United States Monkeypox Therapeutics Market was valued at USD 0.25 Billion in 2022 and is projected to reach USD 0.55 Billion by 2030, growing at a CAGR of 11.3% from 2024 to 2030.
The US Monkeypox Therapeutics Market has witnessed significant growth as the need for effective treatment options increases in response to the 2022 outbreak. The market primarily revolves around antivirals, vaccines, and other supportive therapies aimed at preventing the spread and mitigating the severity of the disease. The rising awareness and demand for preparedness have prompted industries to invest in developing and manufacturing solutions that target the virus, thereby enhancing public health outcomes. Notably, the US market is expected to expand significantly as authorities, healthcare providers, and pharmaceutical companies recognize the importance of managing potential future outbreaks.
One of the most crucial aspects of the US Monkeypox Therapeutics Market is the development and approval of antiviral drugs. These therapeutics are designed to inhibit the replication of the monkeypox virus, ensuring that the disease is controlled before it reaches severe stages. Treatments like Tecovirimat (TPOXX), which is already approved by the FDA for smallpox, have seen expanded usage to combat monkeypox. As research continues, newer antivirals are being developed to increase the effectiveness of existing treatments, thus addressing the increasing demands for better therapeutic options.
From an industry perspective, the growing requirement for Monkeypox therapeutics is also spurred by the demand for preventive vaccines. In response to the outbreak, several vaccine candidates have entered clinical trials to assess their efficacy in preventing monkeypox. These vaccines are especially crucial for high-risk groups, including healthcare workers, laboratory personnel, and those in close contact with infected individuals. Companies focusing on vaccine production are poised to play a pivotal role in the US market’s growth, as governments prepare to safeguard their populations against potential future threats.
The US Monkeypox Therapeutics Market also reflects an evolving need for more advanced diagnostics and surveillance systems. As public health departments strive to detect outbreaks at early stages, the demand for rapid diagnostic tests and effective surveillance tools is paramount. This, in turn, drives the need for cutting-edge technologies and services that can help monitor and track the virus in real-time.
As the world grapples with the challenge of controlling monkeypox, the US market's response demonstrates the importance of collaboration between governments, healthcare providers, and pharmaceutical companies. The collective efforts to meet the increasing therapeutic needs of various industries will determine the pace of innovation in Monkeypox treatment solutions.
Get an In-Depth Research Analysis of the US Monkeypox Therapeutics Market Size And Forecast [2025-2032]
Chimerix Inc.
SIGA Technologies
Inc.
Emergent BioSolutions Inc.
Bavarian Nordic A/S
Hetero Drugs Limited
Mylan N.V.
Piramal Enterprises Limited
Olon S.p.A.
Teva Pharmaceutical Industries Limited
CIDIC Company Limited
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Monkeypox Therapeutics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Monkeypox Therapeutics Market
Antiviral Medications
Vaccines
Supportive Care
Oral
Intravenous
Intramuscular
Subcutaneous
Children
Adults
Immunocompromised Individuals
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Clinics
Nucleotide Analogues
Polymerase Inhibitors
Immune Modulators
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Monkeypox Therapeutics Market Research Analysis
1. Introduction of the US Monkeypox Therapeutics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Monkeypox Therapeutics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Monkeypox Therapeutics Market, By Type
6. US Monkeypox Therapeutics Market, By Application
7. US Monkeypox Therapeutics Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Monkeypox Therapeutics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/